Skip to main content

Staff work in a grow room at Canopy Growth's Tweed facility in Smiths Falls, Ont. on Aug. 23, 2018.

Sean Kilpatrick/The Canadian Press

Constellation Brands Inc. expects to record a loss of about US$54.8-million in its current quarter from its multi-billion-dollar investment in weed producer Canopy Growth Corp., the Corona brewer disclosed in a regulatory filing on Monday.

The brewer’s estimate comes after Canopy’s chief executive officer Mark Zekulin earlier this month told investors it needs another three to five years to turn in a profit.

Constellation invested more than US$4-billion in the loss-making Canopy for a nearly 56-per-cent stake in the marijuana producer, banking on the proposed legalization of recreational weed in several countries.

Story continues below advertisement

In late June, Constellation executives told analysts they were not pleased with Canopy losing money and that they were working with the weed producer to win markets and become profitable.

The very next month, Canopy fired founder and co-chief executive officer Bruce Linton, a move that analysts believe was orchestrated by Constellation.

Canopy has not been able to turn in a profit even as it records soaring sales, as the company invests on new equipments, product research and marketing.

Canopy’s Zekulin earlier this month said the company has lost share in the last eight months as rivals ramped up supply and the company focused on modifying its production base.

Constellation reported a loss of US$1.30 per share in the first quarter compared with a profit of US$3.77 a year ago, mainly due to a 20 cents per share loss related to Canopy.

Editor’s note: (Aug. 27) This wire story has been corrected to show that Constellation made a multi-billion-dollar investment in Canopy Growth.
Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter